4//SEC Filing
ACADIA PHARMACEUTICALS INC 4
Accession 0001415889-13-002575
$ACADCIK 0001070494operating
Filed
Dec 15, 7:00 PM ET
Accepted
Dec 16, 5:43 PM ET
Size
15.6 KB
Accession
0001415889-13-002575
Insider Transaction Report
Form 4
Aasen Thomas H
Exec. VP, CFO & CBO
Transactions
- Gift
Common Stock
2013-12-02−2,000→ 27,348 total - Exercise/Conversion
Common Stock
2013-12-12$6.95/sh+1,000$6,950→ 39,348 total - Exercise/Conversion
Stock Option (right to buy)
2013-12-12−1,000→ 25,000 totalExercise: $6.95Exp: 2015-03-10→ Common Stock (1,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2013-12-12−11,000→ 112,471 totalExercise: $1.55Exp: 2020-03-11→ Common Stock (11,000 underlying) - Exercise/Conversion
Common Stock
2013-12-12$1.55/sh+11,000$17,050→ 38,348 total
Footnotes (4)
- [F1]This disposition reflects a charitable gift made by the reporting person.
- [F2]Includes 5,263 shares acquired on November 29, 2013 by Mr. Aasen under the ACADIA Pharmaceuticals Employee Stock Purchase Plan.
- [F3]25% of the shares subject to the Stock Option vested and became exercisable on March 12, 2011. The remaining shares vest and become exercisable thereafter in 36 equal monthly installments.
- [F4]25% of the shares subject to the Stock Option vested and became exercisable on March 11, 2006. The remaining shares vested and became exercisable thereafter in 36 equal monthly installments.
Documents
Issuer
ACADIA PHARMACEUTICALS INC
CIK 0001070494
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001070494
Filing Metadata
- Form type
- 4
- Filed
- Dec 15, 7:00 PM ET
- Accepted
- Dec 16, 5:43 PM ET
- Size
- 15.6 KB